Improved testing platforms with greater specificity, throughput, and environmental testing capabilities are essential to support public health decisions
Bio-Rad's blood-based immunoassay test can help clinicians identify if an individual has developed antibodies against SARS-CoV-2, the virus associated with COVID-19
PrecisionLife is now offering free use of its unique analytics platform and support from its data and biomedical science teams to those involved in COVID-19 research
A better understanding of coffee microbial partnerships is helpful in determining best management practices and predicting coffee responses to changing conditions
Findings could explain why some COVID-19 patients experience gastrointestinal symptoms, and the fact that the virus often can be detected in stool samples
Researchers at Los Alamos National Labs have been working with the US Department of Energy and other national laboratories on one long-term, safe, disposal solution for nuclear waste—salt
Researchers are studying ways to prevent β-amyloid peptides from forming these dangerous plaques in order to halt development of Alzheimer's disease in the brain
In an examination of 350 published psychological experiments, researchers found that nearly half failed to show that they were based on a valid foundation of empirical evidence
Bio-Rad offers a portfolio of recombinant, monoclonal anti-idiotypic antibodies and drug-target complex binders for the development of highly selective and sensitive assays